Tricuspid regurgitation following lead extraction: Risk factors and clinical course

Israel Medical Association Journal

Volumn 18, Issue 1, 2016, Pages 18-22

  Givon, Amir ^a   Vedernikova, Natalia ^a   Luria, David ^a   Vatury, Ori ^a   Kuperstein, Rafael ^a   Feinberg, Micha S ^a   Eldar, Michael ^a   Glikson, Michael ^a   Nof, Eyal ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cardiac rhythm management device (CRM); Heart failure; Lead extraction; Tricuspid regurgitation (TR)

Indexed keywords

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PACEMAKER; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION; ADVERSE EFFECTS; AGE; AGED; ARTIFICIAL HEART PACEMAKER; DEVICE REMOVAL; ELECTRODE IMPLANT; INCIDENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; TRICUSPID VALVE INSUFFICIENCY; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DEVICE REMOVAL; ECHOCARDIOGRAPHY; ELECTRODES, IMPLANTED; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES; RISK FACTORS; TRICUSPID VALVE INSUFFICIENCY;

EID: 84956873711     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Zhan C, Baine WB, Sedrakyan A, Steiner C. Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis. J Gen Intern Med 2008; 23 (Suppl 1): 13-19.
2. Farooqi FM, Talsania S, Hamid S, Rinaldi CA. Extraction of cardiac rhythm devices: indications, techniques and outcomes for the removal of pacemaker and defibrillator leads. Int J Clin Pract 2010; 64: 1140-7.
3. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-49.
4. Wazni O, Epstein LM, Carrillo RG, et al. Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions. J Am Coll Cardiol 2010; 55: 579-86.
5. Franceschi F, Thuny F, Giorgi R, et al. Incidence, risk factors, and outcome of traumatic tricuspid regurgitation after percutaneous ventricular lead removal. J Am Coll Cardiol 2009; 53: 2168-74.
6. Smith MC, Love CJ. Extraction of transvenous pacing and ICD leads. Pacing Clin Electrophysiol 2008; 31: 736-52.
7. Wilkoff BL, Love CJ, Byrd CL, et al. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm 2009; 6: 1085-104.
8. Bongiorni MG, Soldati E, Zucchelli G, et al. Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: high success rate and safety in more than 2000 leads. Eur Heart J 2008; 29: 2886-93.
9. Assayag P, Thuaire C, Benamer H, Sebbah J, Leport C, Brochet E. Partial rupture of the tricuspid valve after extraction of permanent pacemaker leads: detection by transesophageal echocardiography. Pacing Clin Electrophysiol 1999; 22: 971-4.
10. Roeffel S, Bracke F, Meijer A, et al. Transesophageal echocardiographic evaluation of tricuspid valve regurgitation during pacemaker and implantable cardioverter defibrillator lead extraction. Pacing Clin Electrophysiol 2002; 25: 1583-6.
11. Glover BM, Watkins S, Mariani JA, et al. Prevalence of tricuspid regurgitation and pericardial effusions following pacemaker and defibrillator lead extraction. Int J Cardiol 2010; 145: 593-4.
12. Novak M, Dvorak P, Kamaryt P, Slana B, Lipoldova J. Autopsy and clinical context in deceased patients with implanted pacemakers and defibrillators: intracardiac findings near their leads and electrodes. Europace 2009; 11: 1510-16.
13. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16: 777-802.
14. Hwang JS, Chang I, Kim S. Age-associated decrease in proteasome content and activities in human dermal fibroblasts: restoration of normal level of proteasome subunits reduces aging markers in fibroblasts from elderly persons. J Gerontol A Biol Sci Med Sci 2007; 62: 490-9.
15. Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 2002; 144: 524-9.
16. Abu Sham’a R, Buber J, Grupper A, et al. Effects of tricuspid valve regurgitation on clinical and echocardiographic outcome in patients with cardiac resynchronization therapy. Europace 2012; 15: 266-72.
17. Zipes D, Libby P, Bonow R, Braunwald E. Braunwald’s Heart Disease, a Textbook of Cardiovascular Medicine. 7th edn. Philadelphia: Elsevier Publishing, 2005: chapter 57, p. 1603-6.